Meg Jardine's Publications
About Meg Jardine's Publications
Honorary Professorial Fellow, The George Institute for Global Health- Associate Professor, Faculty of Medicine, UNSW Sydney
-
ASSOCIATION OF NEUROPATHY AND PHYSICAL PARAMETERS IN PEOPLE ON MAINTENANCE HAEMODIALYSIS: A PROSPECTIVE STUDY
Date published: -
IS IMMUNOSUPPRESSIVE THERAPY BENEFICIAL FOR IDIOPATHIC MEMBRANOUS NEPHROPATHY: A SYSTEMATIC REVIEW AND TRIAL SEQUENTIAL ANALYSIS OF PUBLISHED TRIALS
Date published: -
Canagliflozin slows progression of renal function decline independent of glycaemic effects
Date published: -
THE OXFORD CLASSIFICATION SYSTEM (MEST) IN IGA NEPHROPATHY (IGAN): READY FOR ROUTINE CLINICAL PRACTICE?
Date published: -
TRENDS IN THE RELATIVE SURVIVAL OF MIDDLE AGED AND OLDER PEOPLE ON DIALYSIS IN AUSTRALIA
Date published: -
TRENDS IN HAEMOGLOBIN CONCENTRATION AND ERYTHROPOIESIS STIMULATING AGENT (ESA) USE IN THE AUSTRALIAN DIALYSIS POPULATION
Date published: -
Renal effects of canagliflozin in type 2 diabetes mellitus
Current Medical Research and Opinion Date published: -
First Light After the Long Night: A Follow-up Report of the Randomized FHN Nocturnal Trial
American Journal of Kidney Diseases Date published: -
Health-related quality of life in survivors of acute kidney injury: The P rolonged O utcomes S tudy of the R andomized E valuation of N ormal versus A ugmented L evel R eplacement T herapy study outcomes
Nephrology Date published: -
Interventions for lowering plasma homocysteine levels in kidney transplant recipients
Cochrane Database of Systematic Reviews Date published: -
Design and participant baseline characteristics of ‘A C linical T rial of IntensiVE D ialysis’: The ACTIVE D ialysis S tudy
Nephrology Date published: -
EFFECTS OF THE MEDITERRANEAN DIET ON CARDIOVASCULAR OUTCOMES: A SYSTEMATIC REVIEW AND META-ANALYSIS
Journal of the American College of Cardiology Date published: -
THE SHARP-ER STUDY: DESIGN OF THE EXTENDED FOLLOW-UP OF THE SHARP STUDY COHORT
Date published: -
A Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylline (HERO) Trial
American Journal of Kidney Diseases Date published: -
Interventions for preventing intradialytic hypotension in haemodialysis patients
Cochrane Database of Systematic Reviews Date published: -
Angiotensin-converting enzyme inhibitor usage and acute kidney injury: A secondary analysis of RENAL study outcomes
Nephrology Date published: